All Posts by Date or last 15, 30, 90 or 180 days.
also by Lloyd: MacPerformanceGuide.com and WindInMyFace.com

Thank you for buying via links and ads on this site,
which earn me advertising fees or commissions.
As an Amazon Associate I earn from qualifying purchases.

Other World Computing...
B&H Photo...
Amazon
As an Amazon Associate I earn from qualifying purchases.
Upgrade the memory of your 2020 iMac up to 128GB
877-865-7002
Today’s Deal Zone Items... Handpicked deals...
$1100 $880
SAVE $220

$999 $779
SAVE $220

$1299 $949
SAVE $350

$799 $549
SAVE $250

$1499 $999
SAVE $500

$799 $549
SAVE $250

$2797 $2497
SAVE $300

$1997 $1797
SAVE $200

$549 $499
SAVE $50

$1699 $949
SAVE $750

$240 $175
SAVE $65

$3399 $2699
SAVE $700

FDA and CDC OK resuming J&J COVID-19 shots paused over rare clot concerns


re: Lies, Damn Lies, and Statistics: VAERS Reporting for COVID Vaccine Adverse Events vs COVID Deaths
re: The Dismal Anti-Science of Modern Medicine: “less than 0.3% of all adverse drug events and 1-13% of serious events are reported to the Food and Drug Administration”
re: Trust the Process of Science over Time, NOT Scientists and “Experts”
re: Vaccine Safety: “fewer than 1% of vaccine adverse events are reported”

To do proper risk assessment, you have to know the risks of these experimental vaccines. Immediate risks, medium-term risks, and long-term risks. Immediate risks are hardly reported at all, and medium/long term risks are not studied at all.

But fewer than 1% of vaccine adverse events are reported and less than 0.3% of all adverse drug events and 1-13% of serious events are reported to the FDA.

How can these clowns claim safety in light of such incompetent data collection?

FDA and CDC OK resuming J&J COVID-19 shots paused over rare clot concerns

23 April 2021

Experts debated a warning for women under 50, but decided to reinstate the vaccine without one...After reviewing safety data on rare blood clots linked to the Johnson & Johnson COVID-19 vaccine, federal regulators said vaccinations can resume immediately in people 18 and older. The U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention made the ruling April 23 following a meeting of CDC’s Advisory Committee on Immunization Practices about the vaccine, made by Janssen, J&J’s vaccine division. 

“The American public should feel reassured about the safety systems and protocols we have in place around the COVID-19 vaccines,” CDC director Rochelle Walensky said during a news briefing April 23. The system to detect safety concerns identified a small number of cases of rare blood clots accompanied by low platelet counts. The pause gave regulators time to spread the word to doctors and the public about the risk, she said.

Some members of the CDC advisory committee said that they were concerned that the decision doesn’t adequately warn women of an increased risk of rare blood clots. J&J and the FDA have added information to fact sheets about the vaccine that warns of the rare side effect and provides treatment recommendations.

Sign up for e-mail updates on the latest coronavirus news and research

Health officials examined data collected in the vaccine safety reporting system known as VAERS, where anyone can report side effects from vaccines. They found 15 cases of blood clots, all in women, among 7.95 million J&J doses administered. Three women died. 

...

WIND: the last time I heard of “rare” complications, I get severe nerve damage from Metronidazole. Rare means incompetent reporting. The medical establishment is intellectually and ethically corrupt in failing to track side effects in so many areas of medicine. But willful ignorance means better safety profiles and high profits.

You do not find what you are not looking for.

Let’s get this quack science from the CDC and FDA straight:


See also Nikon wishlist
View all handpicked deals...

Apple 13.3" MacBook Air with Retina Display (Early 2020, Gold)
$999 $779
SAVE $220

diglloyd.com | Terms of Use | PRIVACY POLICY
Contact | About Lloyd Chambers | Consulting | Photo Tours
Mailing Lists | RSS Feeds | Twitter
Copyright © 2020 diglloyd Inc, all rights reserved.
Display info: __RETINA_INFO_STATUS__